tagraxofusp: a promising agent for the treatment of pediatric bpdcn
Published 1 year ago • 78 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:48
the safety and efficacy of tagraxofusp for the treatment of bpdcn
-
2:37
recent advances in the treatment of bpdcn & the long-term benefits of tagraxofusp
-
1:17
insights into a study evaluating tagraxofusp for the treatment of bpdcn
-
1:08
tagraxofusp: a breakthrough therapy in bpdcn
-
3:07
frontline treatment in bpdcn & the best route to allogeneic transplantation
-
24:21
aptamer technologies and therapeutics, aptamer research and developments
-
11:13
capture demo video
-
10:41
blastic plasmacytoid dendritic cell neoplasm ( learn in 10 minutes)
-
3:59
the challenges of treating bpdcn and the role of diagnostic markers
-
2:36
tagraxofusp for bpdcn gives encouraging results
-
1:15
managing patients with transplant-ineligible bdpcn with tagraxofusp
-
1:10
current standard of care in bpdcn
-
1:23
the promise of cd123-targeted therapy in bpdcn
-
4:58
elzonris® (tagraxofusp-erzs) mechanism of action in bpdcn
-
1:19
the potential of caplacizumab in the treatment of attp
-
3:05
using patient-derived organoids to investigate bispecific t-cell engager immunotherapy in fl
-
2:41
advances in the treatment and prognosis of ttp
-
8:50
pharmoduct - compounding robot
-
6:07
a crispr approach to hematological research
-
14:46
moving beyond cytotoxic chemotherapy: tagraxofusp-erzs